Research News and Market Data on MGROF
SASKATOON, Saskatchewan, Canada, March 31, 2026 – MustGrow Biologics Corp. (TSXV: MGRO; OTC: MGROF; FRA: 0C0) (the “Company” or “MustGrow“), announces it is to close its wholly-owned Canadian marketing and distribution business NexusBioAg effective April 15, 2026. NexusBioAg had been re-selling and distributing third party products to Canadian farmers, a lower-margin and price-competitive business. Remaining inventory will be sold in subsequent months through existing distribution channels. MustGrow will focus its capital and resources on scaling inventory to meet accelerating demand for its mustard-derived organic biofertility product TerraSante™ in the U.S.
TerraSante™ Sales Growth
In 2025, sales demand from large U.S. commercial farmers outstripped MustGrow’s inventory production. MustGrow’s decision to focus on its proprietary TerraSante™ product in the U.S. requires more focused capital and resources to scale inventory to meet the accelerating demand MustGrow experienced in 2025, and continues to see in 2026.
In January 2026, MustGrow closed a $2 million equity financing, and the proceeds are, in part, being used to build TerraSante™ inventory to meet growing demand for the product. A $2 million credit facility via CIBC and guaranteed by Canada’s Export Development Canada (EDC) has also strengthened MustGrow’s ability to produce inventory. MustGrow utilizes multiple international third-party manufacturers to produce TerraSante™, allowing MustGrow to ramp-up production to meet sales demand, while eliminating the need to build an expensive production plant.
Additionally, MustGrow is assessing multiple global partnership opportunities to expand TerraSante™ internationally.
TerraSante™ for Soil and Ecological Health
MustGrow’s mustard-derived TerraSante™ organic biofertilizer is a wettable powder containing nutritious plant proteins and carbohydrates that feed the soil and soil microbes. TerraSante™ is currently registered and approved for sale in California, Florida, Arizona, Idaho, Oregon, and Washington State, under Organic OMRI Listed® certification and California’s Organic Input Material (OIM) Program.
MustGrow’s biofertility program focuses on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer’s most valuable asset, and MustGrow’s mustard plant-based technologies are being applied with the intention to improve the health of the soil and soil microbiome, and have a positive impact on root and plant health.
TerraSante™ contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and ensuring long-term sustainable soil health. These targeted micro-communities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSante™ has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.
To learn more about TerraSante™, visit TerraSante™ – MustGrow.
About MustGrow
MustGrow Biologics Corp. is a provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company’s technology is centered on harnessing the natural defense mechanisms and organic compounds found in mustard seed and formulating them into organic biofertility, biostimulant, and biocontrol products. These solutions are designed to protect soil health and the soil microbiome, support plant health, and contribute to global food security through more sustainable agricultural practices. In the United States, MustGrow’s flagship biofertility product, TerraSante™, is registered, organically certified, and commercially sold in key agricultural states, including California. Outside of North America, MustGrow is focused on collaborating with leading global agriculture companies, such as Bayer AG in Europe, the Middle East, and Africa, to commercialize its wholly owned proprietary products and technologies. The Company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio, which includes approximately 110 issued and pending patents. MustGrow is publicly traded on the TSX Venture Exchange under the symbol MGRO and has approximately 62.9 million common shares issued and outstanding, and approximately 77.1 million shares on a fully diluted basis.
For further details, please visit www.mustgrow.ca.
Contact Information
Corey Giasson Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
MustGrow Forward-Looking Statements
Certain statements included in this news release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Forward-looking statements in this news release, including statements about: the impact and significance of performance data and field testing, the timing of the closing of NexusBioAg, if at all, the future demand for the Company’s products and the use of proceeds from past financings, and are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include: those risks described in more detail in MustGrow’s Annual Information Form for the year ended December 31, 2024 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.
© 2026 MustGrow Biologics Corp. All rights reserved.